Our study revealed that the increased expression of nucleolin was dramatically associated with aggressive clinicopathological features of patients with HCC, such as advance tumor stage, high tumor grade and high serum level of AFP. The gene discussed is NUCLEOLIN; the disease is hepatocellular carcinoma.